SG/CALL/ZOETIS/200/0.1/19.09.25 Share Price

Warrant

DE000SU95WP7

Real-time Bid/Ask 17:19:43 11/07/2024 BST
1.82 EUR / 1.84 EUR +9.58% Intraday chart for SG/CALL/ZOETIS/200/0.1/19.09.25
Current month-13.02%
1 month-15.66%
Date Price Change
11/07/24 1.68 +0.60%
10/07/24 1.67 -6.70%
09/07/24 1.79 +0.56%
08/07/24 1.78 -2.73%
05/07/24 1.83 -0.54%

Delayed Quote Börse Stuttgart

Last update July 11, 2024 at 08:52 am

More quotes

Static data

Product typeWarrants
Buy / SellCALL
Underlying ZOETIS INC.
IssuerLogo Issuer Société Générale Société Générale
WKN SU95WP
ISINDE000SU95WP7
Date issued 01/03/2024
Strike 200 $
Maturity 19/09/2025 (435 Days)
Parity 10 : 1
Emission price 3.33
Emission volume N/A
Settlement Por diferencias
Currency EUR

Technical Indicators

Highest since issue 3.19
Lowest since issue 0.89
Delta0.48x
Omega 4.302
Premium24.49x
Gearing8.92x
Moneyness 0.8827
Difference Strike 22.96 $
Difference Strike %+11.48%
Spread 0.02
Spread %1.09%
Theoretical value 1.840
Implied Volatility 33.41 %
Total Loss Probability 65.14 %
Intrinsic value 0.000000
Present value 1.840
Break even 219.99 €
Theta-0.02x
Vega0.07x
Rho0.07x

Company Profile

Zoetis Inc. specializes in developing, manufacturing and marketing of animal health products. Net sales break down by activity as follows: - pets (64.4%): cats and dogs (94.9% of net sales) and horses (5.1%); - livestock (34.5%): cattle (51.6% of sales), swine (20.2%), poultry (17.1%), fish (7.6%) and other (3.5%); - other (1.1%). Net sales break down by family of products into parasiticides (23%), vaccines (21.3%), dermatological products (16.4%), anti-infectives (13.4%), medical food additives (4.5%), diagnostic products (4.4%) and other (17%). At the end of 2022, the group has 29 production sites worldwide. The United States accounts for 53.4% of net sales.
Sector
-
More about the company

Ratings for Zoetis Inc.

Trading Rating
Investor Rating
ESG Refinitiv
B+
More Ratings

Consensus: Zoetis Inc.

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
17
Last Close Price
173.5 USD
Average target price
210.2 USD
Spread / Average Target
+21.13%
Consensus